Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity	MTM1 MTMR2 MTMR1	1.29e-05	11	87	3	GO:0052629
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate phosphatase activity	MTM1 MTMR2 MTMR1	2.81e-05	14	87	3	GO:0004438
GeneOntologyMolecularFunction	phosphatidylinositol monophosphate phosphatase activity	MTM1 MTMR2 MTMR1	3.50e-05	15	87	3	GO:0052744
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate phosphatase activity	MTM1 MTMR2 MTMR1	4.29e-05	16	87	3	GO:0106018
GeneOntologyMolecularFunction	phosphatidylinositol bisphosphate phosphatase activity	MTM1 MTMR2 MTMR1	2.17e-04	27	87	3	GO:0034593
GeneOntologyMolecularFunction	phosphatidylinositol phosphate phosphatase activity	MTM1 MTMR2 MTMR1	2.98e-04	30	87	3	GO:0052866
GeneOntologyMolecularFunction	semaphorin receptor activity	PLXNA4 PLXNA2	1.20e-03	12	87	2	GO:0017154
HumanPheno	Ependymoma	CDKN2C NF2 APC TSC1	1.96e-06	19	26	4	HP:0002888
HumanPheno	Dialeptic seizure	CDKN2C GAL NEXMIF AFF3 SCN8A DOCK7 MACF1 TSC1 CHD2	2.22e-06	251	26	9	HP:0011146
HumanPheno	Neoplasm of the anterior pituitary	CDKN2C DNAJB11 NF2 APC TSC1	1.55e-05	65	26	5	HP:0011750
HumanPheno	Neoplasm of the pituitary gland	CDKN2C DNAJB11 NF2 APC TSC1	1.55e-05	65	26	5	HP:0040277
HumanPheno	Carcinoid tumor	CDKN2C APC TSC1	2.52e-05	12	26	3	HP:0100570
HumanPheno	Focal-onset seizure	GAL NF2 NEXMIF AFF3 SCN8A DOCK7 MACF1 TSC1 CHD2	3.08e-05	346	26	9	HP:0007359
HumanPheno	Non-motor seizure	CDKN2C GAL NEXMIF AFF3 SCN8A DOCK7 CHD2	4.09e-05	197	26	7	HP:0033259
HumanPheno	Hypomelanotic macule	CDKN2C KRT5 TSC1	4.14e-05	14	26	3	HP:0009719
HumanPheno	Glioma	CDKN2C NF2 APC TSC1	8.91e-05	48	26	4	HP:0009733
HumanPheno	Pituitary adenoma	CDKN2C DNAJB11 APC TSC1	1.22e-04	52	26	4	HP:0002893
HumanPheno	Abnormal parathyroid morphology	CDKN2C TSC1 CHD7	1.95e-04	23	26	3	HP:0011766
HumanPheno	Generalized non-motor (absence) seizure	CDKN2C NEXMIF AFF3 SCN8A DOCK7 CHD2	2.02e-04	176	26	6	HP:0002121
HumanPheno	Astrocytoma	NF2 APC TSC1	2.52e-04	25	26	3	HP:0009592
HumanPheno	Lipomatous tumor	CDKN2C NF2 APC TSC1	2.59e-04	63	26	4	HP:0012031
HumanPheno	Neoplasm of fatty tissue	CDKN2C NF2 APC TSC1	2.59e-04	63	26	4	HP:0200013
HumanPheno	Unsteady gait	NF2 NEXMIF MTM1 AFF3 SCN8A CHD2 CHD7 RNASEH1	2.74e-04	357	26	8	HP:0002317
HumanPheno	Epileptic encephalopathy	NEXMIF AFF3 SCN8A DOCK7 CHD2	2.84e-04	119	26	5	HP:0200134
HumanPheno	Hypopigmented macule	CDKN2C KRT5 TSC1	2.84e-04	26	26	3	HP:0020073
HumanPheno	Simple febrile seizure	NEXMIF SCN8A CHD2	3.18e-04	27	26	3	HP:0011171
HumanPheno	Focal impaired awareness seizure	GAL SCN8A DOCK7 MACF1 TSC1	3.71e-04	126	26	5	HP:0002384
HumanPheno	Neoplasm of the peripheral nervous system	CDKN2C NF2 APC TSC1	3.89e-04	70	26	4	HP:0100007
HumanPheno	Epileptic spasm	NEXMIF SCN8A DOCK7 MACF1 TSC1 CHD2	4.87e-04	207	26	6	HP:0011097
HumanPheno	Inguinal freckling	KRT5 NF2	5.18e-04	7	26	2	HP:0030052
MousePheno	increased renal carcinoma incidence	CDKN2C NF2 TSC1	2.08e-06	6	67	3	MP:0010384
MousePheno	abnormal retina neuronal layer morphology	ZNF836 ABCA4 PDE4DIP ZNF347 PLXNA4 MACF1 ZNF616 CHD7 RTBDN TUBGCP4 PLXNA2	7.10e-06	441	67	11	MP:0006069
MousePheno	increased kidney tumor incidence	CDKN2C NF2 TSC1	1.23e-05	10	67	3	MP:0010294
MousePheno	abnormal retina layer morphology	ZNF836 ABCA4 PDE4DIP ZNF347 PLXNA4 MACF1 ZNF616 CHD7 RTBDN TUBGCP4 PLXNA2	2.48e-05	504	67	11	MP:0003727
MousePheno	increased urinary system tumor incidence	CDKN2C NF2 TSC1	4.60e-05	15	67	3	MP:0010289
MousePheno	increased osteoma incidence	NF2 APC	6.77e-05	3	67	2	MP:0010313
MousePheno	increased sarcoma incidence	CDKN2C RANBP2 NF2 APC TSC1	1.26e-04	102	67	5	MP:0002032
MousePheno	increased fibroma incidence	NF2 APC	1.35e-04	4	67	2	MP:0003580
MousePheno	abnormal retina outer nuclear layer morphology	ZNF836 ABCA4 PDE4DIP ZNF347 MACF1 ZNF616 TUBGCP4	1.46e-04	240	67	7	MP:0003731
MousePheno	abnormal social/conspecific interaction behavior	SEMG1 DLGAP2 TLE5 NEXMIF DOCK7 APC TSC1 CHD7 CUX1	1.70e-04	421	67	9	MP:0002557
MousePheno	abnormal retina morphology	DNAJB11 ZNF836 ABCA4 CISD2 PDE4DIP ZNF347 PLXNA4 MACF1 ZNF616 TSC1 BICRAL CHD7 RTBDN TUBGCP4 PLXNA2 ZNF445	1.71e-04	1227	67	16	MP:0001325
MousePheno	abnormal ocular fundus morphology	DNAJB11 ZNF836 ABCA4 CISD2 PDE4DIP ZNF347 PLXNA4 MACF1 ZNF616 TSC1 BICRAL CHD7 RTBDN TUBGCP4 PLXNA2 ZNF445	2.37e-04	1262	67	16	MP:0002864
Domain	Myotubularin-like_Pase_dom	MTM1 MTMR2 MTMR1	3.42e-05	14	87	3	IPR010569
Domain	PPASE_MYOTUBULARIN	MTM1 MTMR2 MTMR1	3.42e-05	14	87	3	PS51339
Domain	Myotubularin_fam	MTM1 MTMR2 MTMR1	3.42e-05	14	87	3	IPR030564
Domain	Myotub-related	MTM1 MTMR2 MTMR1	3.42e-05	14	87	3	PF06602
Domain	KRAB	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 ZNF468 ZNF230 ZNF445	4.35e-05	358	87	9	PS50805
Domain	KRAB	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 ZNF468 ZNF230 ZNF445	4.35e-05	358	87	9	PF01352
Domain	GRAM	MTM1 MTMR2 MTMR1	5.23e-05	16	87	3	SM00568
Domain	KRAB	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 ZNF468 ZNF230 ZNF445	5.49e-05	369	87	9	SM00349
Domain	KRAB	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 ZNF468 ZNF230 ZNF445	5.61e-05	370	87	9	IPR001909
Domain	Znf_C2H2-like	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 GPATCH8 ZNF468 ZNF230 ZNF623 ZMAT1 ZNF646 ZNF445	7.69e-05	796	87	13	IPR015880
Domain	Znf_C2H2	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 GPATCH8 ZNF468 ZNF230 ZNF623 ZMAT1 ZNF646 ZNF445	8.61e-05	805	87	13	IPR007087
Domain	ZnF_C2H2	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 GPATCH8 ZNF468 ZNF230 ZNF623 ZMAT1 ZNF646 ZNF445	8.94e-05	808	87	13	SM00355
Domain	TF_AF4/FMR2	AFF3 AFF1	1.28e-04	4	87	2	IPR007797
Domain	AF-4	AFF3 AFF1	1.28e-04	4	87	2	PF05110
Domain	GRAM	MTM1 MTMR2 MTMR1	1.41e-04	22	87	3	PF02893
Domain	GRAM	MTM1 MTMR2 MTMR1	1.41e-04	22	87	3	IPR004182
Domain	Chromo_domain	CDYL2 CHD2 CHD7	1.84e-04	24	87	3	IPR023780
Domain	Chromo	CDYL2 CHD2 CHD7	2.35e-04	26	87	3	PF00385
Domain	ZINC_FINGER_C2H2_2	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 GPATCH8 ZNF468 ZNF230 ZNF623 ZNF646 ZNF445	2.44e-04	775	87	12	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 GPATCH8 ZNF468 ZNF230 ZNF623 ZNF646 ZNF445	2.49e-04	777	87	12	PS00028
Domain	CHROMO_1	CDYL2 CHD2 CHD7	2.94e-04	28	87	3	PS00598
Domain	CHROMO_2	CDYL2 CHD2 CHD7	2.94e-04	28	87	3	PS50013
Domain	-	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 ZNF468 ZNF230 ZNF623 ZNF646 ZNF445	3.07e-04	679	87	11	3.30.160.60
Domain	zf-C2H2	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 ZNF468 ZNF230 ZNF623 ZNF646 ZNF445	3.65e-04	693	87	11	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 ZNF468 ZNF230 ZNF623 ZNF646 ZNF445	3.70e-04	694	87	11	IPR013087
Domain	Chromodomain-like	CDYL2 CHD2 CHD7	4.39e-04	32	87	3	IPR016197
Domain	Chromo/shadow_dom	CDYL2 CHD2 CHD7	4.81e-04	33	87	3	IPR000953
Domain	CHROMO	CDYL2 CHD2 CHD7	4.81e-04	33	87	3	SM00298
Domain	zf-C2H2_6	ZNF836 ZNF611 ZNF808 ZNF616 ZNF468 ZNF646 ZNF445	6.57e-04	314	87	7	PF13912
Domain	Plexin_cytopl	PLXNA4 PLXNA2	7.56e-04	9	87	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA4 PLXNA2	7.56e-04	9	87	2	IPR013548
Domain	Plexin	PLXNA4 PLXNA2	7.56e-04	9	87	2	IPR031148
Domain	PTPc_motif	MTM1 MTMR2 MTMR1	2.63e-03	59	87	3	SM00404
Domain	Tyr_Pase_cat	MTM1 MTMR2 MTMR1	2.63e-03	59	87	3	IPR003595
Domain	Chromodomain_CS	CDYL2 CHD2	3.13e-03	18	87	2	IPR023779
Domain	Tyr_Pase_AS	MTM1 MTMR2 MTMR1	4.80e-03	73	87	3	IPR016130
Domain	IPT	PLXNA4 PLXNA2	6.98e-03	27	87	2	SM00429
Domain	DnaJ_domain_CS	DNAJB12 DNAJB11	6.98e-03	27	87	2	IPR018253
Domain	TYR_PHOSPHATASE_1	MTM1 MTMR2 MTMR1	7.56e-03	86	87	3	PS00383
Domain	TYR_PHOSPHATASE_2	MTM1 MTMR2 MTMR1	7.81e-03	87	87	3	PS50056
Domain	TYR_PHOSPHATASE_dom	MTM1 MTMR2 MTMR1	7.81e-03	87	87	3	IPR000387
Domain	-	MTM1 MTMR2 MTMR1	9.10e-03	92	87	3	3.90.190.10
Domain	TIG	PLXNA4 PLXNA2	9.14e-03	31	87	2	PF01833
Domain	Sema	PLXNA4 PLXNA2	9.14e-03	31	87	2	SM00630
Domain	Semap_dom	PLXNA4 PLXNA2	9.14e-03	31	87	2	IPR001627
Domain	Sema	PLXNA4 PLXNA2	9.14e-03	31	87	2	PF01403
Domain	SEMA	PLXNA4 PLXNA2	9.14e-03	31	87	2	PS51004
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DNAJB12 NF2 TULP4 TLE5 AOPEP SGTA PPP1R12A TOM1L1 AFF3 SEL1L3 APBB2 CDYL2 AFF1 MACF1 BOD1L1 CHD2 ZMAT1 CUX1	5.10e-08	1489	91	18	28611215
Pubmed	Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.	MTM1 MTMR2 MTMR1	6.92e-08	4	91	3	12925573
Pubmed	Functional redundancy in the myotubularin family.	MTM1 MTMR2 MTMR1	6.92e-08	4	91	3	11846405
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	KRT5 DNAJB11 RANBP2 USP42 ZC3H13 DOCK7 APC MTMR1 MACF1 TNKS1BP1 CHD2 CHD7 GPATCH8 CCDC61 IWS1	1.35e-07	1082	91	15	38697112
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SHLD2 NF2 CNST AOPEP PPP1R12A ZC3H13 APC AFF1 MACF1 BOD1L1 CHD2 CHD7 GPATCH8 ZMAT1 ZNF445	1.39e-07	1084	91	15	11544199
Pubmed	A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast.	MTM1 MTMR2 MTMR1	1.73e-07	5	91	3	8640223
Pubmed	Detailed comparative map of human chromosome 19q and related regions of the mouse genome.	CKM ZNF836 ZNF347 HRC ZNF616	9.32e-07	67	91	5	8812484
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PJA2 PDE4DIP SEL1L3 DOCK7 MACF1 TSC1 BOD1L1 GPATCH8 PLXNA2	1.27e-06	407	91	9	12693553
Pubmed	Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human.	MTM1 MTMR2 MTMR1	2.05e-06	10	91	3	9736772
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	DNAJB12 RANBP2 CISD2 COBLL1 DOCK7 APC MTMR1 MACF1 TNKS1BP1 BOD1L1 CRYBG3	2.49e-06	708	91	11	39231216
Pubmed	Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.	APC TSC1 CUX1	3.75e-06	12	91	3	19150975
Pubmed	A human MAP kinase interactome.	KRT5 RANBP2 TLE5 COBLL1 TOM1L1 APC MACF1 BICRAL CUX1	5.37e-06	486	91	9	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF836 TULP4 COBLL1 ZNF347 MACF1 ZNF616 ZNF623 KHDC4 PDZRN4	6.02e-06	493	91	9	15368895
Pubmed	Association of AFF1 rs340630 and AFF3 rs10865035 polymorphisms with systemic lupus erythematosus in a Chinese population.	AFF3 AFF1	6.77e-06	2	91	2	22983539
Pubmed	Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.	MTM1 MTMR2	6.77e-06	2	91	2	28934386
Pubmed	Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells.	MTM1 MTMR1	6.77e-06	2	91	2	12217958
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	ZNF836 ZNF347 ZNF616 ZNF445	8.49e-06	49	91	4	9630514
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	DNAJB11 NEXMIF ZC3H13 MACF1 CHD7 GPATCH8	1.37e-05	197	91	6	20811636
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	DLGAP2 TULP4 PDE4DIP MTMR1 MACF1 TNKS1BP1	1.37e-05	197	91	6	36604605
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	DNAJB12 GDPD1 RANBP2 ZNF28 USP42 DOCK7 ZNF808 CHD2 GPATCH8 ZNF468 ADPGK SBSN ZNF646	1.49e-05	1203	91	13	29180619
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PJA2 PPP1R12A COBLL1 CCDC18 DOCK7 APC MACF1 TNKS1BP1 BOD1L1 CRYBG3 PITPNC1	1.57e-05	861	91	11	36931259
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	PDE4DIP APBB2 APC MACF1 ZNF445	1.65e-05	120	91	5	31413325
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	KRT5 DNAJB11 RANBP2 NF2 MTM1 CCDC18 MTMR2 MTMR1 TSC1 CRYBG3 CCDC61 IWS1	1.88e-05	1049	91	12	27880917
Pubmed	Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly.	DOCK7 APC CUX1	1.91e-05	20	91	3	32294449
Pubmed	Structural Basis for Plexin Activation and Regulation.	PLXNA4 PLXNA2	2.03e-05	3	91	2	27397516
Pubmed	Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers.	PLXNA4 PLXNA2	2.03e-05	3	91	2	17296555
Pubmed	Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells.	PLXNA4 PLXNA2	2.03e-05	3	91	2	18625214
Pubmed	Genomic organization of a 225-kb region in Xq28 containing the gene for X-linked myotubular myopathy (MTM1) and a related gene (MTMR1).	MTM1 MTMR1	2.03e-05	3	91	2	9828128
Pubmed	Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.	PLXNA4 PLXNA2	2.03e-05	3	91	2	22777942
Pubmed	G-quadruplexes in the BAP1 promoter positively regulate its expression.	CHD2 CHD7	2.03e-05	3	91	2	29787736
Pubmed	Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.	NF2 PPP1R12A	2.03e-05	3	91	2	24356468
Pubmed	Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.	MTM1 MTMR2	2.03e-05	3	91	2	28589938
Pubmed	Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.	CHD2 CHD7	2.03e-05	3	91	2	30277262
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DNAJB12 PJA2 DNAJB11 R3HCC1L NF2 CISD2 SGTA ZC3H13 CCDC18 MTMR1 MACF1 CRYBG3 CCDC61 CUX1	3.14e-05	1487	91	14	33957083
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	DNAJB11 RANBP2 NF2 SCN8A APC MTMR1 TUBGCP4 IWS1	3.60e-05	475	91	8	31040226
Pubmed	Endosomal phosphoinositides and human diseases.	MTM1 MTMR2	4.05e-05	4	91	2	18429927
Pubmed	Chromosome assignment of four plexin A genes (Plxna1, Plxna2, Plxna3, Plxna4) in mouse, rat, Syrian hamster and Chinese hamster.	PLXNA4 PLXNA2	4.05e-05	4	91	2	11306810
Pubmed	Nup358 interacts with APC and plays a role in cell polarization.	RANBP2 APC	4.05e-05	4	91	2	19654215
Pubmed	PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure.	PLXNA4 PLXNA2	4.05e-05	4	91	2	25518740
Pubmed	Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP.	MTM1 MTMR2	4.05e-05	4	91	2	12847286
Pubmed	Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice.	AFF3 AFF1	4.05e-05	4	91	2	11923441
Pubmed	Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling.	TLE5 APC	4.05e-05	4	91	2	21251616
Pubmed	Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO.	TLE5 APC	4.05e-05	4	91	2	25432929
Pubmed	Identification of differentially expressed genes in mouse spermatogenesis.	ZNF836 ZNF347 ZNF616	4.84e-05	27	91	3	14581517
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF836 ZC3H13 ZNF347 ZNF616 ZNF623 PLXNA2 CUX1 PHTF1 ZNF646 ZNF445	5.11e-05	808	91	10	20412781
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	CNST DSPP PDE4DIP MACF1 GPATCH8	5.13e-05	152	91	5	34299191
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	RANBP2 SGTA ZC3H13 COBLL1 MTM1 APC TNKS1BP1 IWS1	5.38e-05	503	91	8	16964243
Pubmed	Role of CLASP2 in microtubule stabilization and the regulation of persistent motility.	APC MACF1	6.74e-05	5	91	2	17113391
Pubmed	Guidance-cue control of horizontal cell morphology, lamination, and synapse formation in the mammalian outer retina.	PLXNA4 PLXNA2	6.74e-05	5	91	2	22593055
Pubmed	Obesity promotes PhIP-induced small intestinal carcinogenesis in hCYP1A-db/db mice: involvement of mutations and DNA hypermethylation of Apc.	DOCK7 APC	6.74e-05	5	91	2	27207656
Pubmed	Semaphorin-Plexin signaling influences early ventral telencephalic development and thalamocortical axon guidance.	PLXNA4 PLXNA2	1.01e-04	6	91	2	28438183
Pubmed	Roles of semaphorin-6B and plexin-A2 in lamina-restricted projection of hippocampal mossy fibers.	PLXNA4 PLXNA2	1.01e-04	6	91	2	20484647
Pubmed	Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.	DOCK7 TSC1	1.01e-04	6	91	2	15963462
Pubmed	PtdIns5P regulation through evolution: roles in membrane trafficking?	MTM1 MTMR2	1.01e-04	6	91	2	18774718
Pubmed	The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton.	NF2 TSC1	1.01e-04	6	91	2	12226091
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RANBP2 DOCK7 APC TNKS1BP1 CHD7 CRYBG3 CUX1	1.17e-04	418	91	7	34709266
Pubmed	Tumor suppressor gene mutations in mice.	NF2 APC	1.41e-04	7	91	2	8982467
Pubmed	Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points.	PLXNA4 PLXNA2	1.41e-04	7	91	2	19063725
Pubmed	Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice.	PLXNA4 PLXNA2	1.41e-04	7	91	2	19655386
Pubmed	ErbB2 receptor controls microtubule capture by recruiting ACF7 to the plasma membrane of migrating cells.	APC MACF1	1.41e-04	7	91	2	20937854
Pubmed	Tracing oncogene-driven remodelling of the intestinal stem cell niche.	KRT5 APC	1.41e-04	7	91	2	34079126
Pubmed	FoxO6 affects Plxna4-mediated neuronal migration during mouse cortical development.	PLXNA4 CUX1	1.41e-04	7	91	2	27791111
Pubmed	DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95.	DLGAP2 APC	1.41e-04	7	91	2	9286858
Pubmed	Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.	CKM KRT5 DNAJB11 PDE4DIP CHD7	1.74e-04	197	91	5	23686814
Pubmed	The expression of plexins during mouse embryogenesis.	PLXNA4 PLXNA2	1.88e-04	8	91	2	15661641
Pubmed	Integration of opposing semaphorin guidance cues in cortical axons.	PLXNA4 PLXNA2	1.88e-04	8	91	2	22368082
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RANBP2 USP42 SGTA ZC3H13 AFF1 TNKS1BP1 CHD7 GPATCH8 IWS1	1.97e-04	774	91	9	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	KRT5 NF2 CISD2 DOCK7 APBB2 APC PWWP3A ZMAT1 CUX1	2.03e-04	777	91	9	35844135
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DLGAP2 RANBP2 PPP1R12A PDE4DIP DOCK7 APC MACF1 TSC1 CHD7 CUX1	2.14e-04	963	91	10	28671696
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DOCK7 APC MACF1 TNKS1BP1 CRYBG3	2.28e-04	209	91	5	36779422
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	RANBP2 USP42 TNKS1BP1 BOD1L1 CHD2 CHD7 IWS1	2.37e-04	469	91	7	27634302
Pubmed	Defining the membrane proteome of NK cells.	DNAJB12 GDPD1 KRT5 DNAJB11 RANBP2 AGO4 NF2 CISD2 CNST TUBGCP4 ADPGK	2.38e-04	1168	91	11	19946888
Pubmed	PlexinA4-Semaphorin3A-mediated crosstalk between main cortical interneuron classes is required for superficial interneuron lamination.	PLXNA4 CUX1	2.41e-04	9	91	2	33503438
Pubmed	Semaphorin 6A in Retinal Ganglion Cells Regulates Functional Specialization of the Inner Retina.	PLXNA4 PLXNA2	2.41e-04	9	91	2	38014224
Pubmed	The role of neuropilins in cell signalling.	PLXNA4 PLXNA2	2.41e-04	9	91	2	19909241
Pubmed	A Y2H-seq approach defines the human protein methyltransferase interactome.	NF2 ANKEF1 PDE4DIP DOCK7 CDYL2 TSC1	2.86e-04	342	91	6	23455924
Pubmed	Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development.	PLXNA4 PLXNA2	3.01e-04	10	91	2	18804103
Pubmed	EB1 acetylation by P300/CBP-associated factor (PCAF) ensures accurate kinetochore-microtubule interactions in mitosis.	APC MACF1	3.01e-04	10	91	2	23001180
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	RANBP2 NF2 PDE4DIP MLF1 MACF1 CHD2 ADPGK	3.36e-04	497	91	7	23414517
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	RANBP2 NF2 PPP1R12A DOCK7 MACF1 TNKS1BP1 RNASEH1 IWS1	3.44e-04	660	91	8	32780723
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DLGAP2 KRT5 PPP1R12A PDE4DIP DOCK7 PLXNA4 MTMR2 APC MTMR1 MACF1 TSC1 TNKS1BP1	3.52e-04	1431	91	12	37142655
Pubmed	Nervous-tissue-specific elimination of microtubule-actin crosslinking factor 1a results in multiple developmental defects in the mouse brain.	MACF1 CUX1	3.67e-04	11	91	2	20170731
Pubmed	A Glo1-Methylglyoxal Pathway that Is Perturbed in Maternal Diabetes Regulates Embryonic and Adult Neural Stem Cell Pools in Murine Offspring.	DOCK7 CUX1	3.67e-04	11	91	2	27760310
Pubmed	Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.	DOCK7 CHD7 CUX1	3.69e-04	53	91	3	21532573
Pubmed	Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.	PDE4DIP MACF1 PLXNA2	4.34e-04	56	91	3	9455484
Pubmed	Functional loss of semaphorin 3C and/or semaphorin 3D and their epistatic interaction with ret are critical to Hirschsprung disease liability.	PLXNA4 PLXNA2	4.39e-04	12	91	2	25839327
Pubmed	PLXNA1 and PLXNA3 cooperate to pattern the nasal axons that guide gonadotropin-releasing hormone neurons.	PLXNA4 PLXNA2	4.39e-04	12	91	2	31690636
Pubmed	Ulk4 Regulates Neural Stem Cell Pool.	APC CUX1	4.39e-04	12	91	2	27300315
Pubmed	On and off retinal circuit assembly by divergent molecular mechanisms.	PLXNA4 PLXNA2	4.39e-04	12	91	2	24179230
Pubmed	Deletion of Sema3a or plexinA1/plexinA3 causes defects in sensory afferent projections of statoacoustic ganglion neurons.	PLXNA4 PLXNA2	4.39e-04	12	91	2	23991118
Pubmed	Mouse models in tumor suppression.	NF2 APC	4.39e-04	12	91	2	9917000
Pubmed	Mapping the Hrc gene to proximal mouse chromosome 7: delineation of a conserved linkage group with human 19q.	CKM HRC	4.39e-04	12	91	2	8288260
Pubmed	Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions.	MTMR2 MTMR1	4.39e-04	12	91	2	16787938
Pubmed	Transcriptome profiling reveals expression signatures of cranial neural crest cells arising from different axial levels.	PLXNA4 PLXNA2	4.39e-04	12	91	2	28407732
Pubmed	Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina.	PLXNA4 PLXNA2	4.39e-04	12	91	2	21270798
Pubmed	Impaired macroglial development and axonal conductivity contributes to the neuropathology of DYRK1A-related intellectual disability syndrome.	SCN8A APC	4.39e-04	12	91	2	36402907
Pubmed	AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress.	TSC1 CUX1	4.39e-04	12	91	2	21436046
Pubmed	ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.	NF2 APC TSC1	4.58e-04	57	91	3	23788249
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CDKN2C RANBP2 AFF3 APC AFF1 TNKS1BP1 CHD2 GPATCH8	4.84e-04	695	91	8	23602568
Pubmed	The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development.	NF2 RPTN MACF1	5.07e-04	59	91	3	26371508
Interaction	SCHIP1 interactions	NF2 ZC3H13 MTMR2 MTMR1	1.49e-05	34	89	4	int:SCHIP1
Interaction	SYNE3 interactions	CA9 DNAJB12 DNAJB11 RANBP2 CCDC18 APC MACF1 TSC1 CRYBG3 ADPGK	2.62e-05	444	89	10	int:SYNE3
Interaction	KCNA3 interactions	DNAJB12 RANBP2 NF2 CISD2 COBLL1 DOCK7 APC MTMR1 MACF1 TNKS1BP1 BOD1L1 CHD2 CRYBG3 PHTF1	2.67e-05	871	89	14	int:KCNA3
Cytoband	19q13.41	ZNF836 ZNF28 ZNF611 ZNF808 ZNF616 ZNF468	1.17e-08	78	91	6	19q13.41
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	CKM ZNF836 ZNF28 ZNF347 ZNF611 HRC ZNF808 ZNF616 ZNF468 ZNF230 CCDC61 SBSN	4.25e-06	1192	91	12	chr19q13
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF836 ZNF28 ZNF347 ZNF611 ZNF808 ZNF616 ZNF468 ZNF230 ZNF623 ZNF646 ZNF445	1.25e-05	718	57	11	28
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTM1 MTMR2 MTMR1	1.32e-05	15	57	3	903
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 AFF1	5.84e-05	4	57	2	1145
GeneFamily	Phosphoinositide phosphatases	MTM1 MTMR2 MTMR1	1.38e-04	32	57	3	1079
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 AFF1	3.47e-04	9	57	2	1280
GeneFamily	Plexins	PLXNA4 PLXNA2	3.47e-04	9	57	2	683
GeneFamily	DNA helicases	CHD2 CHD7	1.29e-03	17	57	2	1167
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	DNAJB12 DNAJB11	1.04e-02	49	57	2	584
Coexpression	GSE24210_RESTING_TREG_VS_TCONV_UP	AGO4 CNST COBLL1 AFF3 MTMR1 CHD2 BICRAL	5.93e-06	200	90	7	M7839
Coexpression	TRAVAGLINI_LUNG_PLASMACYTOID_DENDRITIC_CELL	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.11e-05	111	90	5	M41694
Coexpression	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP	NF2 DSPP ANKEF1 PDE4DIP ZNF808 CHD2	5.65e-05	194	90	6	M9980
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	RANBP2 ZC3H13 MTMR1 AFF1 MACF1 KHDC4	6.51e-05	199	90	6	M8381
Coexpression	GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN	TULP4 AFF3 CRYBG3 GPATCH8 CUX1 IWS1	6.51e-05	199	90	6	M6964
Coexpression	GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP	PJA2 AGO4 PDE4DIP AFF3 CRYBG3 PITPNC1	6.69e-05	200	90	6	M8567
Coexpression	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	COBLL1 AFF3 APBB2 TSC1 PITPNC1 ZNF623	6.69e-05	200	90	6	M7518
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	CDKN2C USP51 USP42 PPP1R12A CCDC18 APC MACF1 BOD1L1 CHD2 CHD7 IWS1 ZNF445	1.08e-05	629	88	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	USP51 CCDC18 MACF1 ZNF616 BOD1L1 CHD2 CHD7	1.23e-05	186	88	7	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	PJA2 ZC3H13 COBLL1 AFF3 ZNF616 CHD2 PLXNA2 ZNF445	2.19e-05	281	88	8	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	GDPD1 GANC CISD2 NEXMIF ZC3H13 SCN8A DOCK7 MLF1 APC MACF1 BOD1L1 CHD7 TUBGCP4 ADAT1 PHTF1	2.79e-05	1060	88	15	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	USP51 USP42 PPP1R12A APC MACF1 BOD1L1 CHD2 CHD7 GPATCH8 PLXNA2 ZNF445	3.46e-05	595	88	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	PJA2 ZC3H13 ZNF616 TSC1 CHD2 TUBGCP4 PLXNA2 ZNF445	5.88e-05	323	88	8	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500	ZC3H13 ZNF616 CHD2 TUBGCP4 PLXNA2 ZNF445	8.10e-05	172	88	6	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	GDPD1 TLE5 NEXMIF AFF3 SEL1L3 PLXNA4 AFF1 CHD7 CCDC61 ZMAT1 ADPGK PLXNA2	1.00e-04	791	88	12	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	CA9 GDPD1 ABCA4 GANC ZC3H13 SCN8A DOCK7 APC MTMR1 ZNF616 TSC1 BOD1L1 CHD7 GPATCH8 CUX1 PHTF1	1.44e-04	1370	88	16	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000	PJA2 TULP4 ZNF616 TSC1 TUBGCP4	1.86e-04	127	88	5	gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	ZC3H13 ZNF616 TSC1 CHD2 TUBGCP4 ZNF445	2.41e-04	210	88	6	gudmap_developingGonad_e18.5_ovary_1000_k2
ToppCell	10x5'-Lung-Myeloid_Dendritic-pDC\|Lung / Manually curated celltypes from each tissue	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	2.45e-05	168	91	5	90f713dae3fcbd6ca801a019e3861c263ff3366b
ToppCell	390C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CDKN2C ANKEF1 TOM1L1 BICRAL PLXNA2	2.67e-05	171	91	5	70963f79711fe6088d6d01b29206b17ab89e5e73
ToppCell	COPD-Myeloid-pDC\|World / Disease state, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	2.90e-05	174	91	5	be8227398300711ccda5ecc41ad34064bb246b19
ToppCell	IPF-Myeloid-pDC\|World / Disease state, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	2.98e-05	175	91	5	a06785a4ded01adfd29ca4c20f7759eccbe274cb
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAL KRT5 COBLL1 TOM1L1 CUX1	3.15e-05	177	91	5	f902600c639087664316b3cf30cab243bc3d1c5c
ToppCell	Control-Myeloid-pDC\|Control / Disease state, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.15e-05	177	91	5	3940663bb5b45b2ca9f772550380a516c53e410b
ToppCell	Control-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.15e-05	177	91	5	e82115bfc32c7b689460fbc5caeb983c1aabe30f
ToppCell	COPD-Myeloid-pDC\|COPD / Disease state, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.15e-05	177	91	5	415aa023195a7f961c09529f65cdcc7bb90eaf5d
ToppCell	IPF-Myeloid-pDC\|IPF / Disease state, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.24e-05	178	91	5	8d9e28492e1f157bac3308aa947fd864ca16d277
ToppCell	COPD-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.32e-05	179	91	5	29b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCell	normal_Lung-B_lymphocytes\|normal_Lung / Location, Cell class and cell subclass	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.32e-05	179	91	5	5b89193486100b6754c1c5eca3105ea955805eae
ToppCell	IPF-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.41e-05	180	91	5	0f8567aa835d4e3a52f6631ae15216eca18a030c
ToppCell	moderate-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.41e-05	180	91	5	1d8df7df03a71f49d6683554d3c948ce90dda42e
ToppCell	3'_v3-Lung-Myeloid_Dendritic-pDC\|Lung / Manually curated celltypes from each tissue	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.50e-05	181	91	5	3d7f089fb434fbc989f1fa159e22133ae00b2487
ToppCell	3'_v3-blood-Myeloid_Dendritic-pDC\|blood / Manually curated celltypes from each tissue	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.50e-05	181	91	5	66d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCell	metastatic_Lymph_Node-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.60e-05	182	91	5	02e04294fce12591c32d7bd0e866a000ad1f836e
ToppCell	10x5'-bone_marrow-Myeloid_Dendritic-pDC\|bone_marrow / Manually curated celltypes from each tissue	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.79e-05	184	91	5	2817d530863e85dfdcd143b7a3dc5fc58a9cd98b
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.89e-05	185	91	5	f4588468e8654363f48adbe427dff10f16f1c7fe
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.89e-05	185	91	5	3cb816fc9541c04b4436e21d984216cfbbacff98
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.89e-05	185	91	5	c2e70405969616c28fb6379ee318e17bbcef7b49
ToppCell	Mild-Lymphoid-pDC\|Mild / Condition, Lineage, Cell class and cell subclass	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.99e-05	186	91	5	7fa82972c726025d6402e5eb7bf0db3b699eba4c
ToppCell	tumor_Lung-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.99e-05	186	91	5	3d7c1a281fb82db4471283f39937007d889a5f38
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.99e-05	186	91	5	b031f4e6867b6200b85f43276a34749bf5f4603f
ToppCell	facs-BAT-Fat-24m-Epithelial-Epcam+\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDPD1 KRT5 COBLL1 SBSN PDZRN4	3.99e-05	186	91	5	b18d7398279a2d42414318aeb70514fd402f5a0a
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.99e-05	186	91	5	d2fbf53aac905c9896272ec5c2db28ee1a60f4be
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	PPP1R12A ZC3H13 APC BOD1L1 IWS1	3.99e-05	186	91	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Mild-Lymphoid-pDC-\|Mild / Condition, Lineage, Cell class and cell subclass	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.99e-05	186	91	5	1d05e73ae2ec0cc27f79e4fa40d6b21790059f80
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	3.99e-05	186	91	5	79aedd5aed72509a4925e9f6cb43bc0c798c86f5
ToppCell	Mild_COVID-19-Myeloid-pDC\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.09e-05	187	91	5	99c3c4a7b9179dce7982dc6516d561c952abc80e
ToppCell	COVID-19_Severe-B_memory\|World / disease group, cell group and cell class	ZBED2 COBLL1 AFF3 SEL1L3 CHD7	4.09e-05	187	91	5	f29c71f2505bb64f3010ada491d422b87a6f7db3
ToppCell	COVID-19_Severe-pDC-\|COVID-19_Severe / Disease condition and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.20e-05	188	91	5	9fd1116e31a05554850b8ed3c005ea660dfbd51c
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.20e-05	188	91	5	89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.20e-05	188	91	5	de6a270b6e4fe09c39a52c296632d86ada98465b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CA9 DLGAP2 KRT5 COBLL1 PDZRN4	4.20e-05	188	91	5	9655a4c47b644a870017d349b99063e17dbae572
ToppCell	COVID-19_Mild-pDC\|COVID-19_Mild / Disease condition and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.20e-05	188	91	5	62d33d2990d4a2d32bd0863147e47f656df1966e
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.20e-05	188	91	5	879054b780378ae05be68e597c77c931bf0ade03
ToppCell	COVID-19_Mild-pDC-\|COVID-19_Mild / Disease condition and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.20e-05	188	91	5	a75c2cf2f8dae343c13aaa66b637658b935ed10a
ToppCell	COVID-19_Severe-pDC\|COVID-19_Severe / Disease condition and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.20e-05	188	91	5	475008f45673b42b75ef231c2df91f8b9adc9201
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.31e-05	189	91	5	209cae68d78c8f72479b169e27c3ff7e143adece
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COBLL1 AFF3 APBB2 AFF1 BOD1L1	4.31e-05	189	91	5	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.31e-05	189	91	5	a9ad1fb12304541f909dd0eeac9b9eb28c31fd41
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.31e-05	189	91	5	98ca646231fbd5f29827c2dd31ac4503026bad7d
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.41e-05	190	91	5	adffa93635da10251f28b2089fd96b189775c8b4
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.41e-05	190	91	5	9a91bf1ea105029e6412d0d9060bca325299ce26
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.41e-05	190	91	5	39c8ddc2639bf3e986dae11fbae61a735614b604
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 COBLL1 SEL1L3 PLXNA4 PITPNC1	4.41e-05	190	91	5	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.41e-05	190	91	5	2c1c079fd411c03bc3f383aa927eea9446716960
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic-pDC\|bone_marrow / Manually curated celltypes from each tissue	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.41e-05	190	91	5	dde0e34f6a06cdbbb65c86472360c09f0279a572
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic\|bone_marrow / Manually curated celltypes from each tissue	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.41e-05	190	91	5	6892c603037b61ef88d6ca01b7592dc0d347d63b
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.41e-05	190	91	5	a95aea3aa707fc4574810706341a5f32b3d00209
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.41e-05	190	91	5	18dfa84c62dcf081ce9958a71e76a394ec0968e4
ToppCell	BAL-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.53e-05	191	91	5	989bf108c7f2c78dd7f14481570f1819673a5469
ToppCell	Control-pDC\|Control / Disease condition and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.53e-05	191	91	5	543e1437a52d04436862dd1c27b4fae95c44fcc8
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKM PDE4DIP MLF1 HRC PDZRN4	4.53e-05	191	91	5	c172c9e17b893b290e4aa8af5e5e4cd3e4818372
ToppCell	Control-pDC-\|Control / Disease condition and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.53e-05	191	91	5	1d7b0fae4d114d6db933c18b4eb2066ffa61356d
ToppCell	Healthy-pDC\|World / disease group, cell group and cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.53e-05	191	91	5	6e1d825dc33b915b95f13ccd237a552160a4be98
ToppCell	BAL-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.53e-05	191	91	5	3e7fbe4af2c23b3b964becde843d2f088ad41c23
ToppCell	BAL-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.53e-05	191	91	5	bc2f3c4e71e3a55fe76ea03f45746329a8fc81da
ToppCell	COVID-19-Lymphoid-pDC\|COVID-19 / Condition, Lineage and Cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.53e-05	191	91	5	25343b11d42128ad16659e5519cd1673266cc505
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKM PDE4DIP MLF1 HRC PDZRN4	4.53e-05	191	91	5	715f5b449b8e075959c05a5b38389df319663164
ToppCell	BAL-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.64e-05	192	91	5	d9ff2293358c8b031ba212021012e058014ff472
ToppCell	Severe_COVID-19-Myeloid-pDC\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.64e-05	192	91	5	f79424c643a375dfe4579eff7ac1ba191e28a283
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COBLL1 AFF3 SEL1L3 APBB2 CHD7	4.64e-05	192	91	5	ef86d82e4f04f9f54e821ef496d70fc81072d773
ToppCell	BAL-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.64e-05	192	91	5	2e8611d65090e39f1a6e74c972288e7b68376d15
ToppCell	droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKM PDE4DIP MLF1 HRC PDZRN4	4.64e-05	192	91	5	0bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell	MS-Treg-exh_CD4\|MS / Condition, Cell_class and T cell subcluster	CNST PDE4DIP DOCK7 TSC1 ZNF623	4.64e-05	192	91	5	c6722bf142c84ccedd99c1a3344085aecb4cbab4
ToppCell	Healthy-pDC\|Healthy / disease group, cell group and cell class	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.64e-05	192	91	5	33d695a28d22b4af111df9591830a33bb7ef7b2d
ToppCell	BAL-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 COBLL1 AFF3 SEL1L3 PLXNA4	4.64e-05	192	91	5	43569726df281eebe57499e0993b9fd9d36118c2
ToppCell	droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKM PDE4DIP MLF1 HRC PDZRN4	4.64e-05	192	91	5	d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	PJA2 SGTA COBLL1 AFF3 SEL1L3	4.76e-05	193	91	5	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	Control-Lymphoid_B-B_naive\|Control / Disease group, lineage and cell class	COBLL1 AFF3 SEL1L3 APBB2 CHD7	4.87e-05	194	91	5	4f9600960a287cfc020c06b4af3528d4e5797916
ToppCell	COVID-19_Severe-B_memory\|COVID-19_Severe / disease group, cell group and cell class	ZBED2 COBLL1 AFF3 SEL1L3 CHD7	4.99e-05	195	91	5	54becd9e283639638fc5f13eddce224aed9391da
ToppCell	Healthy_donor-B_naive\|World / disease group, cell group and cell class (v2)	COBLL1 AFF3 SEL1L3 APBB2 CHD7	4.99e-05	195	91	5	c66bbfdf0091cc62aa50edfa88820bbda191b7bb
ToppCell	mild_COVID-19-B_naive\|mild_COVID-19 / disease group, cell group and cell class (v2)	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.12e-05	196	91	5	00398079d3ac14dc2026c0cbd7388f1f3257b134
ToppCell	Healthy/Control-B_naive\|Healthy/Control / Disease group and Cell class	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.12e-05	196	91	5	e92d2c814d2dcb049f3e455fe66fd40898b3524d
ToppCell	Healthy_donor-B_naive\|Healthy_donor / disease group, cell group and cell class (v2)	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.12e-05	196	91	5	cf254b1466357984201595fa32408d659eb741ef
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.12e-05	196	91	5	d7e6c89cb49933b4a86d26d15f6772f2481d37ef
ToppCell	Healthy/Control-B_naive\|World / Disease group and Cell class	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.12e-05	196	91	5	ec935a4e16495c87b17070eb13c1e28bdb64e7ee
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.12e-05	196	91	5	fcbfd8c4771d99a45fc53e482ef98edabe8ef591
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.12e-05	196	91	5	f45cb8f714ae7ac800768df65f299b98a2d42962
ToppCell	mild-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBED2 COBLL1 AFF3 SEL1L3 CHD7	5.50e-05	199	91	5	e6ac9a0959b0de2c6a99298feb7715aa80ade1dd
ToppCell	mild-B_memory\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBED2 COBLL1 AFF3 SEL1L3 CHD7	5.50e-05	199	91	5	025bb65629d9e20c374e8f1ba08c36d1bb569190
ToppCell	COVID-19-COVID-19_Mild-Myeloid-pDC\|COVID-19_Mild / Disease, condition lineage and cell class	COBLL1 AFF3 SEL1L3 PLXNA4 CRYBG3	5.50e-05	199	91	5	9de61e5189d907cc969ac3043d68204f70acc0bf
ToppCell	severe-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.63e-05	200	91	5	0e86f52b6e146d9bbc728d8fb176fc2b53696558
ToppCell	Control-Control-Lymphocyte-B-B_naive\|Control / Disease, condition lineage and cell class	COBLL1 AFF3 SEL1L3 APBB2 CHD7	5.63e-05	200	91	5	15e4b9956b9a0c2e6927a802e86e1cb4bb18b89a
ToppCell	mLN-Dendritic_cell-pDC\|Dendritic_cell / Region, Cell class and subclass	KRT5 DNAJB11 COBLL1 SEL1L3 PLXNA4	5.63e-05	200	91	5	10ae1ac8a98346320a92e855aebb3a7109f0ab9b
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	ZC3H13 APC BOD1L1 IWS1	1.84e-04	138	91	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	TULP4 AFF3 PLXNA4 PLXNA2	2.41e-04	148	91	4	a1269312903fc27830c1835dabf660c659a711be
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZBED2 COBLL1 SEL1L3 CHD7	2.47e-04	149	91	4	2cd860b96ed4be4d26844085d464961c1418054a
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	KRT5 AFF3 SEL1L3 PLXNA4	2.94e-04	156	91	4	19472ef1642c2ad333aa3ce3675a25c6ab1d4556
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Interneuron\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	PDE4DIP CUX1 PDZRN4	3.05e-04	64	91	3	fefabdf8d72a8f3caf78eb79d759edb475bdb2ad
ToppCell	facs-Heart-RV-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKM TLE5 MLF1 HRC	3.09e-04	158	91	4	2ef43d14ee65d004dc62c12ff209bbe12e4db681
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COBLL1 AFF3 SEL1L3 CHD7	3.24e-04	160	91	4	7ad065337ac802de52c15ee715f6b78a3eed0cef
ToppCell	Influenza_Severe-B_memory\|Influenza_Severe / Disease group and Cell class	COBLL1 AFF3 SEL1L3 CHD7	3.64e-04	165	91	4	51172acaeb667b34b8b8c7878d67cfa0c4a2dffc
ToppCell	facs-Heart-LA-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKM RPTN MLF1 HRC	3.72e-04	166	91	4	829a8998ce68739a58202851afd73e049ab0f84f
ToppCell	facs-Heart-LA-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKM RPTN MLF1 HRC	3.72e-04	166	91	4	c43aec09578975df8984886993d15b42a10190c8
ToppCell	10x5'-Liver-Myeloid_Dendritic-pDC\|Liver / Manually curated celltypes from each tissue	KRT5 COBLL1 AFF3 SEL1L3	3.72e-04	166	91	4	24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44
ToppCell	368C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	GDPD1 BICRAL ZNF230 RNASEH1	3.81e-04	167	91	4	dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43
ToppCell	VE-Treg-exh_CD4\|VE / Condition, Cell_class and T cell subcluster	GDPD1 TULP4 MLF1 PHTF1	3.81e-04	167	91	4	1036ac1ef9440612500137af9d1929672b077e4d
ToppCell	normal_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	CA9 KRT5 ZBED2 SBSN	3.81e-04	167	91	4	892a2dc83ab5de5a1016402f8e95d2aabf651326
Drug	Kawain [500-64-1]; Down 200; 17.4uM; HL60; HT_HG-U133A	TLE5 DSPP SGTA MTM1 MLF1 APC PWWP3A MACF1	1.20e-06	198	90	8	2337_DN
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	DNAJB12 NF2 AOPEP COBLL1 PDE4DIP APC PHTF1	1.24e-05	195	90	7	5004_DN
Drug	Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A	NF2 SGTA COBLL1 PDE4DIP ZNF611 MTMR2 APBB2	1.29e-05	196	90	7	5984_DN
Drug	Monocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DNAJB12 R3HCC1L NF2 COBLL1 MLF1 MTMR1 BICRAL	1.33e-05	197	90	7	6771_DN
Disease	centronuclear myopathy X-linked (implicated_via_orthology)	MTM1 MTMR2 MTMR1	2.05e-06	9	87	3	DOID:0111225 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	MTM1 MTMR2 MTMR1	4.79e-05	24	87	3	DOID:10595 (implicated_via_orthology)
Disease	free cholesterol to total lipids in large LDL percentage	COBLL1 DOCK7 AFF1 MACF1	6.93e-05	74	87	4	EFO_0022280
Disease	Epilepsy, Cryptogenic	NEXMIF SCN8A TSC1 CHD2	1.03e-04	82	87	4	C0086237
Disease	Awakening Epilepsy	NEXMIF SCN8A TSC1 CHD2	1.03e-04	82	87	4	C0751111
Disease	Aura	NEXMIF SCN8A TSC1 CHD2	1.03e-04	82	87	4	C0236018
Disease	level of Phosphatidylcholine (18:2_18:2) in blood serum	DOCK7 PLXNA4	1.28e-04	6	87	2	OBA_2045106
Disease	CHARGE syndrome (implicated_via_orthology)	CHD2 CHD7	1.79e-04	7	87	2	DOID:0050834 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in medium LDL percentage	COBLL1 DOCK7 AFF1	1.79e-04	37	87	3	EFO_0022252
Disease	triglycerides in large LDL measurement	COBLL1 DOCK7 AFF1	2.81e-04	43	87	3	EFO_0022319
Disease	Gastrointestinal Hemorrhage	GAL APC	3.05e-04	9	87	2	C0017181
Disease	Epilepsy	NEXMIF SCN8A TSC1 CHD2	3.10e-04	109	87	4	C0014544
Disease	myopathy (implicated_via_orthology)	MTM1 MTMR2 MTMR1	3.89e-04	48	87	3	DOID:423 (implicated_via_orthology)
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	COBLL1 DOCK7 AFF1	4.65e-04	51	87	3	EFO_0022302
Disease	cholesterol to total lipids in small HDL percentage	COBLL1 DOCK7 AFF1	4.65e-04	51	87	3	EFO_0022240
Disease	triglycerides in HDL measurement	COBLL1 DOCK7 AFF1	5.21e-04	53	87	3	EFO_0022317
Disease	free cholesterol to total lipids in small LDL percentage	COBLL1 DOCK7 AFF1	5.21e-04	53	87	3	EFO_0022286
Disease	triglycerides in medium HDL measurement	COBLL1 DOCK7 AFF1	5.51e-04	54	87	3	EFO_0022321
Disease	total lipids in medium VLDL	COBLL1 DOCK7 AFF1	5.51e-04	54	87	3	EFO_0022153
Disease	triglycerides in medium VLDL measurement	COBLL1 DOCK7 AFF1	5.81e-04	55	87	3	EFO_0022155
Disease	cholesterol to total lipids in large HDL percentage	COBLL1 DOCK7 AFF1	5.81e-04	55	87	3	EFO_0022234
Disease	triglycerides in LDL measurement	COBLL1 DOCK7 AFF1	6.13e-04	56	87	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	COBLL1 DOCK7 AFF1	6.13e-04	56	87	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	COBLL1 DOCK7 AFF1	6.13e-04	56	87	3	EFO_0022333
Disease	triglycerides in large VLDL measurement	COBLL1 DOCK7 AFF1	6.13e-04	56	87	3	EFO_0022178
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	COBLL1 DOCK7 AFF1	6.13e-04	56	87	3	EFO_0022316
Disease	cholesteryl esters to total lipids in medium HDL percentage	COBLL1 DOCK7 AFF1	6.13e-04	56	87	3	EFO_0022251
Disease	triglycerides in IDL measurement	COBLL1 DOCK7 AFF1	6.79e-04	58	87	3	EFO_0022149
Disease	triglycerides in VLDL measurement	COBLL1 DOCK7 AFF1	7.14e-04	59	87	3	EFO_0022326
Disease	triglycerides to total lipids in small LDL percentage	COBLL1 DOCK7 AFF1	7.14e-04	59	87	3	EFO_0022337
Disease	phospholipids in VLDL measurement	COBLL1 DOCK7 AFF1	7.14e-04	59	87	3	EFO_0022301
Disease	cholesteryl esters to total lipids in large HDL percentage	COBLL1 DOCK7 AFF1	7.14e-04	59	87	3	EFO_0022248
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	COBLL1 DOCK7 AFF1	7.14e-04	59	87	3	EFO_0022260
Disease	triglycerides to total lipids in large HDL percentage	COBLL1 DOCK7 AFF1	7.50e-04	60	87	3	EFO_0022330
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	COBLL1 DOCK7 AFF1	7.50e-04	60	87	3	EFO_0021898
Disease	total lipids in VLDL measurement	COBLL1 DOCK7 AFF1	7.50e-04	60	87	3	EFO_0022314
Disease	cholesterol to total lipids in IDL percentage	CKM COBLL1 MACF1	7.50e-04	60	87	3	EFO_0022233
Disease	cholesterol to total lipids in medium HDL percentage	COBLL1 DOCK7 AFF1	7.50e-04	60	87	3	EFO_0022237
Disease	triglycerides in small VLDL measurement	COBLL1 DOCK7 AFF1	7.87e-04	61	87	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	COBLL1 DOCK7 AFF1	7.87e-04	61	87	3	EFO_0022274
Disease	free cholesterol in VLDL measurement	COBLL1 DOCK7 AFF1	7.87e-04	61	87	3	EFO_0022276
Disease	triglycerides in medium LDL measurement	COBLL1 DOCK7 AFF1	8.26e-04	62	87	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	COBLL1 DOCK7 AFF1	8.26e-04	62	87	3	EFO_0022339
Disease	triglycerides in small HDL measurement	COBLL1 DOCK7 AFF1	8.26e-04	62	87	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	COBLL1 DOCK7 AFF1	8.26e-04	62	87	3	EFO_0022169
Disease	total lipids in chylomicrons and extremely large VLDL measurement	COBLL1 DOCK7 AFF1	8.26e-04	62	87	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	COBLL1 DOCK7 AFF1	8.26e-04	62	87	3	EFO_0022313
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	COBLL1 DOCK7 AFF1	8.26e-04	62	87	3	EFO_0022263
Disease	phospholipids in very large VLDL measurement	COBLL1 DOCK7 AFF1	8.26e-04	62	87	3	EFO_0022299
Disease	free cholesterol to total lipids in medium LDL percentage	COBLL1 DOCK7 AFF1	8.65e-04	63	87	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	COBLL1 DOCK7 AFF1	8.65e-04	63	87	3	EFO_0022292
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	COBLL1 DOCK7 AFF1 MACF1	8.85e-04	144	87	4	EFO_0004611, EFO_0020943
Disease	Headache	CDKN2C MACF1 CUX1	9.06e-04	64	87	3	HP_0002315
Disease	triglycerides in small LDL measurement	COBLL1 DOCK7 AFF1	9.48e-04	65	87	3	EFO_0022323
Disease	cholesterol in large VLDL measurement	COBLL1 DOCK7 AFF1	9.48e-04	65	87	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	COBLL1 DOCK7 AFF1	9.48e-04	65	87	3	EFO_0022230
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	COBLL1 DOCK7 AFF1 MACF1	1.03e-03	150	87	4	EFO_0004611, EFO_0020947
Disease	total lipids in small VLDL	COBLL1 DOCK7 AFF1	1.03e-03	67	87	3	EFO_0022148
Disease	total lipids in large VLDL	COBLL1 DOCK7 AFF1	1.03e-03	67	87	3	EFO_0022175
Disease	triglycerides to phosphoglycerides ratio	COBLL1 DOCK7 AFF1	1.08e-03	68	87	3	EFO_0022327
Disease	triglycerides in very small VLDL measurement	COBLL1 DOCK7 AFF1	1.08e-03	68	87	3	EFO_0022144
Disease	free cholesterol in large VLDL measurement	COBLL1 DOCK7 AFF1	1.08e-03	68	87	3	EFO_0022265
Disease	autism spectrum disorder (implicated_via_orthology)	NEXMIF TSC1 CHD2 CHD7	1.08e-03	152	87	4	DOID:0060041 (implicated_via_orthology)
Disease	Familial Progressive Myoclonic Epilepsy	TSC1 CHD2	1.14e-03	17	87	2	C0751777
Disease	Atypical Inclusion-Body Disease	TSC1 CHD2	1.14e-03	17	87	2	C0751776
Disease	Myoclonic Epilepsies, Progressive	TSC1 CHD2	1.14e-03	17	87	2	C0751778
Disease	Biotin-Responsive Encephalopathy	TSC1 CHD2	1.14e-03	17	87	2	C0751780
Disease	May-White Syndrome	TSC1 CHD2	1.14e-03	17	87	2	C0751782
Disease	Dentatorubral-Pallidoluysian Atrophy	TSC1 CHD2	1.14e-03	17	87	2	C0751781
Disease	Malignant neoplasm of breast	CDKN2C KRT5 ABCA4 NF2 ANKEF1 AFF1 MACF1 BOD1L1 CUX1 ZNF646	1.24e-03	1074	87	10	C0006142
Disease	triglycerides to total lipids in small HDL percentage	COBLL1 DOCK7 AFF1	1.27e-03	72	87	3	EFO_0022336
Disease	Action Myoclonus-Renal Failure Syndrome	TSC1 CHD2	1.28e-03	18	87	2	C0751779
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	COBLL1 DOCK7 AFF1	1.61e-03	78	87	3	EFO_0022187
Disease	left atrial function	DSPP AOPEP	1.74e-03	21	87	2	EFO_0004294
Disease	fatty acid measurement	ABCA4 COBLL1 DOCK7 PLXNA4 AFF1 MACF1	1.85e-03	436	87	6	EFO_0005110
Disease	cortical surface area measurement	CDKN2C AOPEP ZC3H13 MTMR2 APC AFF1 MACF1 CHD7 PLXNA2 CUX1 PDZRN4	1.98e-03	1345	87	11	EFO_0010736
Disease	Neurodevelopmental Disorders	NEXMIF SCN8A CHD2	2.65e-03	93	87	3	C1535926
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	COBLL1 DOCK7 AFF1	2.82e-03	95	87	3	EFO_0004529, EFO_0008317, EFO_0008596
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	COBLL1 DOCK7 AFF1 MACF1	2.94e-03	200	87	4	EFO_0004611, EFO_0020945

Protein segments in the cluster

Peptide	Gene	Start	Entry
HGGDLTKAAHNNSEN	AFF3	926	P51826
GNGKDHSILHSRNDL	ADPGK	101	Q9BRR6
VERSHHQKSLANSGG	CCDC61	461	Q9Y6R9
EQNRGNHHGTAEEKS	APBB2	176	Q92870
GHHGPRKSRDSENQS	CRYBG3	2106	Q68DQ2
LHHKRNEEAQDLSGG	ABCA4	1051	P78363
ERGGEVNAFDNDRHH	ANKEF1	206	Q9NU02
SNANGTKADGRADDH	DLGAP2	251	Q9P1A6
HDGIHGKEENITANG	DSPP	121	Q9NZW4
DKDGNHDNQEHASGI	AOPEP	111	Q8N6M6
ESKHGEGALDQLQHD	CCDC144NL	61	Q6NUI1
DKDHDSAEGSHVSGQ	AGO4	821	Q9HCK5
HATGKHSESNAELGQ	CHD7	1886	Q9P2D1
NSFDGKHQDHNLSDS	COBLL1	611	Q53SF7
REVTNGAAHHQSFGK	ADAT1	206	Q9BUB4
QNNAHRDKEGDDQSH	CA9	126	Q16790
FALRVGHGNDNHADA	MTMR1	481	Q13613
AHETHRDSGFKNVGD	R3HCC1L	356	Q7Z5L2
NKNHETDGGSAHGDD	RANBP2	1151	P49792
SNNHEKDSGVGRTDE	PDZRN4	546	Q6ZMN7
NETSDREDGLPKGHH	IWS1	51	Q96ST2
TAGRHGDDLRNTKHE	KRT5	371	P13647
LHKFHENDNGAAAGD	CUX1	661	Q13948
SSSQDHGGRKHKGEL	GPATCH8	776	Q9UKJ3
KNHDHGDQKEGDRGS	PLXNA2	1656	O75051
KNHEHGDQKEGDRGS	PLXNA4	1656	Q9HCM2
HAESHQLKNTGDGDA	GANC	231	Q8TET4
GGLLNSDHRVSHEEK	MACF1	601	O94854
QLRVGHGDKNHADAD	MTMR2	461	Q13614
KHISHRGGAGENLEN	GDPD1	41	Q8N9F7
HGKEHKADATQAREG	TUBGCP4	421	Q9UGJ1
LHNENSDRGGSSKHN	NF2	561	P35240
GTGVNSNSEKHADHR	BOD1L1	1186	Q8NFC6
TASNVGHRNHKGDTA	CDKN2C	126	P42773
DKAAHETQFGRSDQH	BICRAL	831	Q6AI39
GKHSERSNHAEAAQC	DOCK7	1696	Q96N67
KDAHGNHLAEELGAS	CCDC18	1181	Q5T9S5
EDHGKGRENGYQSLH	CHD2	676	O14647
HAVGNHRSFSDKNGL	GAL	46	P22466
DQFGDDKSQAARHGH	DNAJB12	171	Q9NXW2
EEGLKDGHQSSHGDI	DNAJB11	91	Q9UBS4
SSDEEEEHGGHKNAS	KHDC4	571	Q7Z7F0
AHHAAGQAGKELQNA	SBSN	516	Q6UWP8
NQLDGDGHEHLTSSD	CNST	41	Q6PJW8
KDDGSGQTRLHGHQI	NUP210L	841	Q5VU65
GGAQDESGSRIHHKN	PWWP3A	196	Q2TAK8
ARSQQHHGLAADLGK	RTBDN	36	Q9BSG5
KHGGERQEACHLHNS	SEL1L3	466	Q68CR1
EEIDAHQHKGAQNDG	TOM1L1	461	O75674
HDQLRHGGLSSDAQE	SGTA	16	O43765
HKTDLNHENLKGGDD	CKM	106	P06732
CNDQRHASNHKEDGG	NEXMIF	656	Q5QGS0
DLLSHEQKGRHQHGS	SEMG1	416	P04279
HINSDKGLEEHTGSQ	SHLD2	326	Q86V20
HRSQDHKVGDEGVSG	HRC	106	P23327
QDRLGQEGFGSSHHK	AFF1	161	P51825
SQNKHETGSHDAERQ	APC	246	P25054
AGSEKDERHFGNGSH	CDYL2	161	Q8N8U2
DGSHNKHNELTGDNV	CISD2	111	Q8N5K1
SQAHLSKEDKNGHDG	TLE5	171	Q08117
SKEDKNGHDGDTHQE	TLE5	176	Q08117
EGHENQHGQESEAKA	RNASEH1	81	O60930
STVGHGDRDHEHLQK	TULP4	786	Q9NRJ4
LHRHSKDDSGGQEAN	USP51	461	Q70EK9
NLSDRFHEHENGKSR	USP42	1146	Q9H9J4
GHNEEASGHNGETKT	TSC1	1006	Q92574
HREELEKSGHGQAGQ	ZBED2	106	Q9BTP6
GKRDQHSQGDVENNH	ZNF616	121	Q08AN1
RIGHGDKNHTDADRS	MTM1	421	Q13496
EGAHVNTLHSGTKRD	PHTF1	401	Q9UMS5
DANEQGQDLGKRDHH	TNKS1BP1	901	Q9C0C2
AHNRRGHNDGEDSLT	MLF1	51	P58340
SKHSHEQSDRGEGVE	PITPNC1	26	Q9UKF7
ERHGLTHGAGEKENS	ZNF646	591	O15015
TGSTDQHDHRHAGNK	ZNF808	136	Q8N4W9
ANHTGADIHRNGDFQ	SCN8A	1046	Q9UQD0
THGNSNIDAAKSDRG	TTLL2	431	Q9BWV7
GNLTHGRDEHDKRDA	ZNF347	161	Q96SE7
SSGFDHHLGDQSGEK	ZNF445	581	P59923
HRSFCKDQQGDHNGE	ZNF230	431	Q9UIE0
GSTGQHDQRHAGNKH	ZNF28	121	P17035
TGSTDQHDHRHAGNK	ZNF611	136	Q8N823
HLGERSVDKGEHTGN	ZNF623	521	O75123
RQDRDSHHGQSEKQD	RPTN	151	Q6XPR3
ADHTGAGVSQSLRHK	TRBV7-1	16	A0A0A6YYK4
IKELAGSTGQHDQRH	ZNF468	116	Q5VIY5
GSTGQHDQRHAGNKR	ZNF468	121	Q5VIY5
DGKHGEDNDHLQLSA	PJA2	171	O43164
NDSAHRSGDDQSGRK	ZC3H13	1211	Q5T200
DSGNLSNHKRIHTGE	ZNF836	621	Q6ZNA1
LSSENNTADHQAGHK	ZMAT1	521	Q5H9K5
DATDGSFANKHGRHV	PDE4DIP	2166	Q5VU43
NSGHINDVRHAKSGG	PPP1R12A	186	O14974